載入...
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
As the most important viral cause of severe respiratory disease in infants and increasing recognition as important in the elderly and immunocompromised, respiratory syncytial virus (RSV) is responsible for a massive health burden worldwide. Prophylactic antibodies were successfully developed against...
Na minha lista:
| 發表在: | Influenza Other Respir Viruses |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BlackWell Publishing Ltd
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4474493/ https://ncbi.nlm.nih.gov/pubmed/25847510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12313 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|